Answers are grounded in this paper and cite their sources.
Randomized controlled trial shows early intervention reduces atopic dermatitis and enhances safety in children, suggesting potential impact on allergic disease outcomes.
Early enhanced AD intervention was associated with a sustained modest reduction in its planned primary follow-up outcome of FA and safety (growth) up to age 3. Although most differences were small and may reflect early diagnosis and good overall management in both groups, the findings support early AD treatment as a potential strategy to modify allergic disease trajectories.
No takes yet. Share an insight, caveat, or question.
Yamamoto‐Hanada et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: